Documents by Dr. Roland Griffiths and Dr. Matthew Johnson of Johns Hopkins University School of Medicine, presented as testimony opposing efforts to make Salvia divinorum and salvinorin A Schedule I controlled substance in the state of Maryland

The authors present a well-reasoned, scientifically informed, perspective on the relative safety of Salvia divinorum and its importance in medical research. They argue that excessively restrictive regulation would seriously impede promising medical research.



Scientific Considerations Concerning Saliva divinorum and Salvinorin A: Implications for Proposed Legislation

Testimony on Regulation of Salvia divinorum.

Domains of Concern for Drugs of Abuse:

An Overview of Various Drug Regulation Options